GlassScriptPhysician profile
Stefano Schena
NPI 1447465356
$5,154.70
in general payments reported to CMS, 2019-2025
10 companies · $822 in 2025
The $822 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $76.31 · 2021: $250 · 2022: $371 · 2023: $2,337 · 2024: $1,045 · 2025: $822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,985 · Travel and Lodging: $1,218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,984.82 |
| Travel and Lodging | $1,218.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $3,503.75 | 2023-2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryosphere Cryoablation System, Synergy Ablation System |
| Edwards Lifesciences Corporation | $422.13 | 2019-2025 | Inspiris Resilia Aortic Valve |
| Abbott Laboratories | $348.74 | 2022-2025 | Epic |
| Medtronic, INC. | $250.18 | 2021 | |
| Medtronic Vascular, INC. | $204.96 | 2019-2020 | |
| Helios Cardio INC | $147.55 | 2023 | |
| Abiomed | $128.03 | 2022 | |
| Baxter Healthcare | $111.61 | 2025 | Preveleak |
| Livanova USA, INC. | $22.05 | 2023 | Protekduo |
| Teleflex LLC | $15.70 | 2025 | Manta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stefano Schena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.